Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17496 clinical trials
Featured trial
Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies

The study will determine Recommended Phase 2 Dose for all study drugs, based on the safety and tolerability of the following combinations: INCAGN02385 + INCAGN02390 and INCAGN02385 + INCAGN02390 + INCMGA00012.  

  • 2 views
  • 10 May, 2022
  • 2 locations
Featured trial
  • 127 views
  • 02 Sep, 2021
  • 1 location
Featured trial
ATLAS: A Randomized, Double-blind, Placebo-controlled Phase 3 Study of JNJ-56021927 in Subjects With High-risk, Localized or Locally Advanced Prostate Cancer Receiving Treatment With Primary Radiation Therapy. NCT02531516, PCR3003.

The purpose of this study is to determine if apalutamide plus gonadotropin releasing hormone (GnRH) agonist in participants with high-risk, localized or locally advanced prostate cancer receiving

  • 60 views
  • 02 Sep, 2021
  • 1 location
Featured trial
BLOOD SAMPLE COLLECTION- UNTREATED MELANOMA

MELANOMA, ALSO KNOWN AS MALIGNANT MELANOMA, IS A TYPE OF CANCER THAT DEVELOPS FROM THE PIGMENT-CONTAINING CELLS KNOWN AS MELANOCYTESUP OF FAT IN THE LIVER.  

  • 88 views
  • 03 Oct, 2019
  • 1 location
Featured trial
Healthy Male Research Study

Looking for males 18-65 years of age, non-smokers, no drug or alcohol in take within past 30 years, no history of cancer, hep, hiv, high cholesterol or high blood pressure. Restrictions apply.

  • 557 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) Patients that are Treatment Naive or Receiving Bruton s-Tyrosine Kinase Inhibitor (BTK-I) Therapy

Background: People who have cancer tend to get sick more often. This is in part because of the cancer treatments they get. Because of this, they may get shingles

acalabrutinib
chronic lymphocytic leukemia
cancer
lymphoma
ibrutinib
  • 228 views
  • 09 Apr, 2019
  • 1 location
Featured trial
Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Background: Chronic lymphocytic leukemia (CLL) is a cancer of white blood cells. It is also called small lymphocytic lymphoma (SLL). It causes tiredness, night sweats

thrombocytopenia
fatigue
night sweats
lymphadenopathy
cancer
  • 348 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma(CLL/SLL), Lymphoplasmacytic Lymphoma(LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma(SMZL)

, but patients may be asked to undergo these procedures for research purposes) Clinical information is collected and stored in a central databank. Patients whose cancer requires

waldenstrom's macroglobulinemia
chronic lymphocytic leukemia
lymphadenopathy
marginal zone lymphoma
lymphoma
  • 115 views
  • 15 Apr, 2019
  • 1 location
Featured trial
A Pilot Phase II Study Using Ibrutinib and Short-Course Fludarabine in Previously Untreated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Background: Chronic lymphocytic leukemia (CLL) and/or small lymphocytic lymphoma (SLL) are tumors of abnormal B cells that often affect elderly patients. Studies have

thrombocytopenia
fatigue
night sweats
lymphadenopathy
lymphoma
  • 169 views
  • 15 Apr, 2019
  • 1 location